Sign in

You're signed outSign in or to get full access.

David I. Schachter

Vice President at Gabelli Healthcare & WellnessRx Trust
Executive

About David I. Schachter

Vice President of The Gabelli Healthcare & WellnessRx Trust (GRX), born in 1953, serving since 2007; he also serves across the Gabelli closed‑end fund complex and is Senior Vice President of G.research, LLC since 2015 . Schachter joined Gabelli in 1998 after a career focused on closed‑end funds at Thomas J. Herzfeld Advisors, Smith Barney, Drexel Burnham, and Laidlaw Adams & Peck; he holds a BA from Queens College and an MA from New York University . Fund‑level operating metrics (revenue/EBITDA) are not applicable to a closed‑end fund officer, and GRX does not disclose TSR tied to his role; portfolio performance is overseen by portfolio managers and trustees rather than the Vice President position .

Past Roles

OrganizationRoleYearsStrategic Impact
Laidlaw, Adams & PeckRegistered Representative1978 onward (early career)Began Wall Street career; initiated closed‑end fund focus
Drexel BurnhamRegistered Representative/Closed‑end fund focusPre‑1994Deepened coverage of closed‑end funds and industry participants
Smith Barney (New York)Specialized in closed‑end fundsPrior to 1994Specialized sales/analysis of closed‑end funds; industry relationships
Thomas J. Herzfeld AdvisorsWriter/Analyst; contributed to “The Investor’s Guide to Closed‑End Funds”1994–1998Sector thought leadership; attended fund annual meetings; engagement with managers/activists

External Roles

OrganizationRoleYearsStrategic Impact
Gabelli Fund Complex (Closed‑End Funds)Vice President and/or OmbudsmanSince 2007Investor relations, shareholder communications across Gabelli CEFs
G.research, LLCSenior Vice PresidentSince 2015Sell‑side/issuer liaison functions supporting fund complex
Gabelli Utility Trust; Gabelli Global Utility & Income Trust; other Gabelli CEFsVice President &/or Ombudsman (multiple funds)Various (ongoing)Cross‑fund governance/IR continuity within complex
Media (CNBC, CNN)Commentator on closed‑end fundsNot disclosedPublic education, visibility of closed‑end fund strategies
CredentialNASD representativeNot disclosedRegulatory registration credential

Fixed Compensation

  • GRX’s proxy discloses trustee fees and, where applicable, fund‑paid officer compensation; Bethany A. Uhlein (VP & Ombudsman) received $75,622 in FY2024, but no compensation is disclosed for David I. Schachter—indicating he is not paid directly by the Fund (compensation generally flows via the Adviser) .
  • Base salary, bonus targets/actuals, and perquisites for Schachter are not disclosed in GRX filings; skip.

Performance Compensation

  • GRX does not disclose RSUs/PSUs, options, performance metrics, or vesting schedules for Schachter; skip.

Equity Ownership & Alignment

  • Beneficial ownership tables in the 2025 proxy list trustees and certain officers; Schachter is not listed with reportable GRX holdings, and no share pledging or hedging disclosures are made for him .
  • Section 16(a) reporting compliance for insiders was affirmed for FY2024; no delinquent filings noted .

Employment Terms

  • Employment agreements, severance, change‑of‑control, non‑compete/solicit, garden leave, consulting arrangements, clawbacks, or ownership guidelines for Schachter are not disclosed by GRX; skip.

Investment Implications

  • Compensation alignment: Absence of fund‑paid compensation disclosures or equity awards for Schachter suggests limited direct pay‑for‑performance signal for this officer; governance and portfolio outcomes are primarily driven by trustees, portfolio managers, and the adviser .
  • Retention risk: Long tenure (Vice President since 2007) and broader Gabelli complex responsibilities (joined in 1998; SVP at G.research since 2015) indicate organizational continuity and low near‑term retention risk .
  • Insider selling pressure: No reported GRX holdings or vesting schedules for Schachter; fund noted full Section 16 compliance, implying low near‑term selling pressure risk tied to his account .
  • Trading signals and governance context:
    • Activist ownership: Saba Capital disclosed 13.3% of GRX common shares as of 6/30/2025, signaling potential corporate governance and discount‑to‑NAV catalysts around meetings and policies .
    • Preferred control dynamics: Gabelli affiliates and related entities collectively hold a majority of GRX preferred shares, shaping governance outcomes for preferred elections and potentially affecting capital structure actions .
    • Control share statute: GRX is subject to Delaware Statutory Trust control share provisions, constraining voting rights at specified thresholds unless approved; the Board has exempted acquisitions of preferred directly from the Fund/distributors, which may influence activist strategies and meeting outcomes .

Net: Schachter’s role is investor‑relations/governance support across Gabelli closed‑end funds; material trading and compensation levers for GRX are more closely tied to activist dynamics (e.g., Saba), preferred shareholder concentration by Gabelli affiliates, and Board/manager actions than to Schachter’s individual incentives .

Sources

  • GRX DEF 14A (2025): Officers, roles, tenure, governance and ownership tables .
  • Gabelli team bio: Education, career history (Herzfeld, Smith Barney, Drexel, Laidlaw), media, credentials .
  • MarketScreener: Cross‑fund roles within Gabelli complex .
  • Activist filing: Saba Capital Schedule 13D/A (GRX common) .
  • GRX Annual/Semiannual materials (supportive officer listings): SEC N‑CSR/N‑CSRS and Annual Report references .